Senti Biosciences, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2021 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Senti Biosciences, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2021 to Q3 2024.
  • Senti Biosciences, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$28.9M, a 93.4% decline year-over-year.
  • Senti Biosciences, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$123M, a 11.5% decline year-over-year.
  • Senti Biosciences, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$71.1M, a 22.1% decline from 2022.
  • Senti Biosciences, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$58.2M, a 5.23% decline from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$123M -$28.9M -$13.9M -93.4% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 -$109M -$11.2M +$7.49M +40.1% Apr 1, 2024 Jun 30, 2024 10-Q 2024-11-14
Q1 2024 -$117M -$12.1M +$6.61M +35.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-11-14
Q4 2023 -$123M -$71.1M -$12.8M -22.1% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-21
Q3 2023 -$111M -$14.9M +$1.72M +10.3% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 -$112M -$18.7M -$7.15M -61.9% Apr 1, 2023 Jun 30, 2023 10-Q 2024-11-14
Q1 2023 -$105M -$18.7M -$6.91M -58.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-11-14
Q4 2022 -$98.2M -$58.2M -$26.3M -82.4% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-21
Q3 2022 -$71.9M -$16.6M -$5.23M -45.9% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$66.7M -$11.6M +$455K +3.79% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-14
Q1 2022 -$67.1M -$11.8M -$11.8M Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-14
Q4 2021 -$55.3M -$31.9M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-22
Q3 2021 -$11.4M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$12M Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-10
Q1 2021 -$1.18K* Mar 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q1 2021 -$21M Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.